About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Lymphadenectomy In Ovarian Neoplasms | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT00712218

Lymphadenectomy In Ovarian Neoplasms

To assess the efficacy of systematic pelvic and para-aortic lymphadenectomy in patients with advanced ovarian cancer and intra-abdominal complete debulking. Secondary: progression-free survival, comp...

Lead sponsor: Philipps University Marburg•59 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Philipps University Marburg

Collaborators

German Research Foundation

Age

18 - 75 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Primary diagnosis of invasive epithelial ovarian cancer FIGO stage IIB-IV (IV only if resectable metastasis in pleura, liver, spleen, and/or abdominal wall)
•Macroscopic complete resection
•Age: 18 - 75 years
•Patients who have given their signed and written informed consent
•Good performance status (ECOG 0/1)

Exclusion Criteria

•Non epithelial ovarian malignancies and borderline tumors
•Intraoperative clinically suspicious lymph nodes (bulky nodes)
•Secondary invasive neoplasms in the last 5 years (except synchronal endometrial carcinoma FIGO IA G1/2, non melanoma skin cancer, breast cancer T1 N0 M0 G1/2) or with any signs of relapse or activity.
•Recurrent ovarian cancer
•Prior chemotherapy for ovarian cancer or abdominal/pelvic radiotherapy
•Diseases of the lymph system (including lymph edema of unknown origin)
•Clinical relevant dysfunctions of blood clotting (including medicamentous conditioned reasons, e.g. ASS, if not stopped at least 7 days prior to surgery)
•Any significant medical reasons, age or performance status that will not allow to perform the study procedures (estimation of investigator)
•Prior retroperitoneal lymph node dissection (systematic or sampling)
•Pregnancy
•Dementia or significantly altered mental status that would prohibit the understanding and giving of informed consent
•Any reasons interfering with regular follow-up

Related studies

Familial Investigations of Childhood Cancer Predisposition

NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more

RECRUITINGPhase 1

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more

RECRUITINGPhase 1

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

NCT06964009 · Ovarian Cancer, Ovarian Carcinoma, and more

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

NCT00539162 · Ovarian Cancer

RECRUITINGPhase 1

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403 · Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 4, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment640

Start dateDec 2008

Last updatedMar 4, 2020

Condition

Locations shown

Universitaetsklinik Graz

Graz

Universitaetskliniken LKH Innsbruck

Innsbruck

AKH Wien

Vienna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 4, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions